- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The optical characteristics of physiological tissue can be measured using diffuse optical tomography (DOT) and imaging (DOI), two non-invasive approaches.The techniques operate best on soft tissues like breast and brain tissue because they rely on the thing being studied being at least somewhat translucent or light-transparent.
Regional variations in oxy and deoxy-haemoglobin concentration as well as cellular scattering can be observed by tracking spatial-temporal variations in tissue's light absorption and scattering properties.
Using model-based reconstruction methods, it is possible to create spatial maps of tissue characteristics such as total haemoglobin concentration, blood oxygen saturation, and scattering based on these measurements.
DOT and DOI have been employed in numerous deep-tissue applications including breast cancer imaging, brain functional imaging, stroke detection, muscle functional studies,photodynamic treatment,and radiation therapy monitoring.
Diffuse optical tomography can be used to examine blood flow to the tissues and track changes in their oxygen content. It could be possible to distinguish between healthy and diseased tissue in this way. Using diffuse optical tomography to examine soft tissue, such as breast and brain tissue, may be very beneficial.
The GlobalDiffuse optical tomography (DOT) Market accountedfor $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
A technique for imaging that makes use of fluorescence-based or near-infrared spectroscopy (NIRS) is diffuse optical imaging (DOI).
Diffuse optical tomography is the name given to DOI when it is used to generate 3D volumetric models of the substance that was observed; 2D imaging techniques are referred to as diffuse optical imaging.
Several fields, including neuroscience, sports medicine, wound monitoring, and cancer detection, can benefit from the technique.
The concentrations of oxygenated and deoxygenated haemoglobin are typically monitored using DOI methods, which may also assess the redox states of cytochromes.
Depending on the application, the technique may also be known as diffuse optical tomography (DOT), near infrared optical tomography (NIROT), or fluorescent diffuse optical tomography (FDOT).
DOT technology can be employed in both scientific and therapeutic domains thanks to benefits including portability, direct measurements of haemoglobin status, temporal resolution, and non-restricted motions as occurs in magnetic resonance imaging (MRI) devices.
In this review, we discussed neurophysiology, the physical theories that underlie optical imaging when tissue and light interact, and the technology that is frequently used to build DOT devices, including the specifications for source detectors to enhance image quality.
Because of intricate mathematical models that characterise the light propagation through the tissue head, DOT can produce 3D images of cerebral activation.
Unlike intrusive treatments like surgical interventions, neuroimaging technology delivers information that allows an advance in our understanding of how the brain functions. Additionally,neuroimaging technologies can have a potential application in the prognosis and diagnosis of diseases.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.